INBRX-109
Ph2 INBRX-109 SA CS
Phase 2 small_molecule active
Quick answer
INBRX-109 for Conventional Chondrosarcoma is a Phase 2 program (small_molecule) at Inhibrx Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Inhibrx Biosciences
- Indication
- Conventional Chondrosarcoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active